Please login to the form below

Not currently logged in
Email:
Password:

Eric Terhaerdt leaves AZ for Astellas

Joins as senior VP of global development operations

Eric Terhaerdt, AstellasAstellas has turned to AstraZeneca for its new senior VP of global development operations.

Eric Terhaerdt spent more than 20 years at AZ, most recently serving as VP, head of scientific and technical evaluations.

He will now lead the global direction of the drug development operations at Japan-based Astellas, working primarily in the Netherlands and the US.

Terhaerdt has extensive knowledge of the global pharmaceutical market having worked across the world for AZ in countries such as the UK, the US, Sweden, Hungary and the Czech Republic.

Dr Bernie Zeiher, executive VP, global development, welcomed Terhaerdt to the company: "His diverse international experience in drug development, strategic planning and change management will help Astellas continue to address the unmet needs of our patients."

20th January 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics